npj Parkinsons Disease-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1221085, encodeId=4bc7122108524, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿2个多月，写信询问还没有分配编辑，太差太差了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71221470103, createdName=guanqianglu, createdTime=Fri May 20 05:53:44 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196312, encodeId=4a9a1196312bf, content=Decision Sent to Author 21st Feb 22 Waiting to Send Decision to Author 18th Feb 22 Manuscript Under Consideration 18th Feb 22 Manuscript Under Consideration 31st Jan 22 Editor Assigned 24th Jan 22 Manuscript Received 24th Jan 22 2.15才分配编辑 I have asked one of the Associate Editors, Prof. Nicolas Dzamko, to assist me with the assessment and possible peer review of your manuscript and I will contact you as soon as this process is complete. 真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:59:23 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214982, encodeId=2da71214982d9, content=投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：投稿40天左右收到送审邮件，还在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ed4739502, createdName=498260625, createdTime=Wed Apr 27 10:11:49 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207611, encodeId=7652120e611da, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：初审两个月才拒，实在太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5f26584305, createdName=ms9000001319861801, createdTime=Thu Mar 31 18:00:57 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196310, encodeId=b98c119631049, content=不说审稿，半个月才分配编辑，一个月以后编辑拒绝了。服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:57:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193777, encodeId=07a41193e77fc, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:44:40 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083523, encodeId=3b58108352363, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：2021/08/16 Manuscript Received、Editor Assigned、Manuscript Under Consideration 2021/08/24 Associate Editor assigned 2021/08/27 Manuscript Under Consideration 2021/09/01 Waiting to Send Decision to Author 2021/09/02 Editorial decision: Reject before peer review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 12:04:05 CST 2021, time=2021-12-23, status=1, ipAttribution=)]

2022-05-20 guanqianglu

审稿速度:3.0 | 投稿命中率:25.0
经验分享：投稿2个多月，写信询问还没有分配编辑，太差太差了

70 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1221085, encodeId=4bc7122108524, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿2个多月，写信询问还没有分配编辑，太差太差了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71221470103, createdName=guanqianglu, createdTime=Fri May 20 05:53:44 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196312, encodeId=4a9a1196312bf, content=Decision Sent to Author 21st Feb 22 Waiting to Send Decision to Author 18th Feb 22 Manuscript Under Consideration 18th Feb 22 Manuscript Under Consideration 31st Jan 22 Editor Assigned 24th Jan 22 Manuscript Received 24th Jan 22 2.15才分配编辑 I have asked one of the Associate Editors, Prof. Nicolas Dzamko, to assist me with the assessment and possible peer review of your manuscript and I will contact you as soon as this process is complete. 真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:59:23 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214982, encodeId=2da71214982d9, content=投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：投稿40天左右收到送审邮件，还在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ed4739502, createdName=498260625, createdTime=Wed Apr 27 10:11:49 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207611, encodeId=7652120e611da, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：初审两个月才拒，实在太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5f26584305, createdName=ms9000001319861801, createdTime=Thu Mar 31 18:00:57 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196310, encodeId=b98c119631049, content=不说审稿，半个月才分配编辑，一个月以后编辑拒绝了。服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:57:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193777, encodeId=07a41193e77fc, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:44:40 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083523, encodeId=3b58108352363, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：2021/08/16 Manuscript Received、Editor Assigned、Manuscript Under Consideration 2021/08/24 Associate Editor assigned 2021/08/27 Manuscript Under Consideration 2021/09/01 Waiting to Send Decision to Author 2021/09/02 Editorial decision: Reject before peer review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 12:04:05 CST 2021, time=2021-12-23, status=1, ipAttribution=)]

2022-02-23 ms6000000926635472

Decision Sent to Author 21st Feb 22
Waiting to Send Decision to Author 18th Feb 22
Manuscript Under Consideration 18th Feb 22
Manuscript Under Consideration 31st Jan 22
Editor Assigned 24th Jan 22
Manuscript Received 24th Jan 22

2.15才分配编辑
I have asked one of the Associate Editors, Prof. Nicolas Dzamko, to assist me with the assessment and possible peer review of your manuscript and I will contact you as soon as this process is complete.

真慢啊

112 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1221085, encodeId=4bc7122108524, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿2个多月，写信询问还没有分配编辑，太差太差了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71221470103, createdName=guanqianglu, createdTime=Fri May 20 05:53:44 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196312, encodeId=4a9a1196312bf, content=Decision Sent to Author 21st Feb 22 Waiting to Send Decision to Author 18th Feb 22 Manuscript Under Consideration 18th Feb 22 Manuscript Under Consideration 31st Jan 22 Editor Assigned 24th Jan 22 Manuscript Received 24th Jan 22 2.15才分配编辑 I have asked one of the Associate Editors, Prof. Nicolas Dzamko, to assist me with the assessment and possible peer review of your manuscript and I will contact you as soon as this process is complete. 真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:59:23 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214982, encodeId=2da71214982d9, content=投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：投稿40天左右收到送审邮件，还在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ed4739502, createdName=498260625, createdTime=Wed Apr 27 10:11:49 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207611, encodeId=7652120e611da, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：初审两个月才拒，实在太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5f26584305, createdName=ms9000001319861801, createdTime=Thu Mar 31 18:00:57 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196310, encodeId=b98c119631049, content=不说审稿，半个月才分配编辑，一个月以后编辑拒绝了。服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:57:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193777, encodeId=07a41193e77fc, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:44:40 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083523, encodeId=3b58108352363, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：2021/08/16 Manuscript Received、Editor Assigned、Manuscript Under Consideration 2021/08/24 Associate Editor assigned 2021/08/27 Manuscript Under Consideration 2021/09/01 Waiting to Send Decision to Author 2021/09/02 Editorial decision: Reject before peer review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 12:04:05 CST 2021, time=2021-12-23, status=1, ipAttribution=)]

2022-04-27 498260625

投稿命中率:25.0
偏重的研究方向：帕金森病
经验分享：投稿40天左右收到送审邮件，还在等待中

77 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1221085, encodeId=4bc7122108524, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿2个多月，写信询问还没有分配编辑，太差太差了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71221470103, createdName=guanqianglu, createdTime=Fri May 20 05:53:44 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196312, encodeId=4a9a1196312bf, content=Decision Sent to Author 21st Feb 22 Waiting to Send Decision to Author 18th Feb 22 Manuscript Under Consideration 18th Feb 22 Manuscript Under Consideration 31st Jan 22 Editor Assigned 24th Jan 22 Manuscript Received 24th Jan 22 2.15才分配编辑 I have asked one of the Associate Editors, Prof. Nicolas Dzamko, to assist me with the assessment and possible peer review of your manuscript and I will contact you as soon as this process is complete. 真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:59:23 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214982, encodeId=2da71214982d9, content=投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：投稿40天左右收到送审邮件，还在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ed4739502, createdName=498260625, createdTime=Wed Apr 27 10:11:49 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207611, encodeId=7652120e611da, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：初审两个月才拒，实在太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5f26584305, createdName=ms9000001319861801, createdTime=Thu Mar 31 18:00:57 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196310, encodeId=b98c119631049, content=不说审稿，半个月才分配编辑，一个月以后编辑拒绝了。服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:57:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193777, encodeId=07a41193e77fc, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:44:40 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083523, encodeId=3b58108352363, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：2021/08/16 Manuscript Received、Editor Assigned、Manuscript Under Consideration 2021/08/24 Associate Editor assigned 2021/08/27 Manuscript Under Consideration 2021/09/01 Waiting to Send Decision to Author 2021/09/02 Editorial decision: Reject before peer review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 12:04:05 CST 2021, time=2021-12-23, status=1, ipAttribution=)]

2022-03-31 ms9000001319861801

审稿速度:2.0 | 投稿命中率:25.0
经验分享：初审两个月才拒，实在太慢了

106 0

[GetPortalCommentsPageByObjectIdResponse(id=1221085, encodeId=4bc7122108524, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿2个多月，写信询问还没有分配编辑，太差太差了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71221470103, createdName=guanqianglu, createdTime=Fri May 20 05:53:44 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196312, encodeId=4a9a1196312bf, content=Decision Sent to Author 21st Feb 22 Waiting to Send Decision to Author 18th Feb 22 Manuscript Under Consideration 18th Feb 22 Manuscript Under Consideration 31st Jan 22 Editor Assigned 24th Jan 22 Manuscript Received 24th Jan 22 2.15才分配编辑 I have asked one of the Associate Editors, Prof. Nicolas Dzamko, to assist me with the assessment and possible peer review of your manuscript and I will contact you as soon as this process is complete. 真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:59:23 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214982, encodeId=2da71214982d9, content=投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：投稿40天左右收到送审邮件，还在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ed4739502, createdName=498260625, createdTime=Wed Apr 27 10:11:49 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207611, encodeId=7652120e611da, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：初审两个月才拒，实在太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5f26584305, createdName=ms9000001319861801, createdTime=Thu Mar 31 18:00:57 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196310, encodeId=b98c119631049, content=不说审稿，半个月才分配编辑，一个月以后编辑拒绝了。服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:57:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193777, encodeId=07a41193e77fc, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:44:40 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083523, encodeId=3b58108352363, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：2021/08/16 Manuscript Received、Editor Assigned、Manuscript Under Consideration 2021/08/24 Associate Editor assigned 2021/08/27 Manuscript Under Consideration 2021/09/01 Waiting to Send Decision to Author 2021/09/02 Editorial decision: Reject before peer review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 12:04:05 CST 2021, time=2021-12-23, status=1, ipAttribution=)]

2022-02-23 ms6000000926635472

不说审稿，半个月才分配编辑，一个月以后编辑拒绝了。服了

125 0

[GetPortalCommentsPageByObjectIdResponse(id=1221085, encodeId=4bc7122108524, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿2个多月，写信询问还没有分配编辑，太差太差了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71221470103, createdName=guanqianglu, createdTime=Fri May 20 05:53:44 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196312, encodeId=4a9a1196312bf, content=Decision Sent to Author 21st Feb 22 Waiting to Send Decision to Author 18th Feb 22 Manuscript Under Consideration 18th Feb 22 Manuscript Under Consideration 31st Jan 22 Editor Assigned 24th Jan 22 Manuscript Received 24th Jan 22 2.15才分配编辑 I have asked one of the Associate Editors, Prof. Nicolas Dzamko, to assist me with the assessment and possible peer review of your manuscript and I will contact you as soon as this process is complete. 真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:59:23 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214982, encodeId=2da71214982d9, content=投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：投稿40天左右收到送审邮件，还在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ed4739502, createdName=498260625, createdTime=Wed Apr 27 10:11:49 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207611, encodeId=7652120e611da, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：初审两个月才拒，实在太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5f26584305, createdName=ms9000001319861801, createdTime=Thu Mar 31 18:00:57 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196310, encodeId=b98c119631049, content=不说审稿，半个月才分配编辑，一个月以后编辑拒绝了。服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:57:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193777, encodeId=07a41193e77fc, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:44:40 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083523, encodeId=3b58108352363, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：2021/08/16 Manuscript Received、Editor Assigned、Manuscript Under Consideration 2021/08/24 Associate Editor assigned 2021/08/27 Manuscript Under Consideration 2021/09/01 Waiting to Send Decision to Author 2021/09/02 Editorial decision: Reject before peer review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 12:04:05 CST 2021, time=2021-12-23, status=1, ipAttribution=)]

2022-02-15 梅斯助教

#期刊推荐#

124 0

[GetPortalCommentsPageByObjectIdResponse(id=1221085, encodeId=4bc7122108524, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：投稿2个多月，写信询问还没有分配编辑，太差太差了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71221470103, createdName=guanqianglu, createdTime=Fri May 20 05:53:44 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196312, encodeId=4a9a1196312bf, content=Decision Sent to Author 21st Feb 22 Waiting to Send Decision to Author 18th Feb 22 Manuscript Under Consideration 18th Feb 22 Manuscript Under Consideration 31st Jan 22 Editor Assigned 24th Jan 22 Manuscript Received 24th Jan 22 2.15才分配编辑 I have asked one of the Associate Editors, Prof. Nicolas Dzamko, to assist me with the assessment and possible peer review of your manuscript and I will contact you as soon as this process is complete. 真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:59:23 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214982, encodeId=2da71214982d9, content=投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：投稿40天左右收到送审邮件，还在等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ed4739502, createdName=498260625, createdTime=Wed Apr 27 10:11:49 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207611, encodeId=7652120e611da, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：初审两个月才拒，实在太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5f26584305, createdName=ms9000001319861801, createdTime=Thu Mar 31 18:00:57 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196310, encodeId=b98c119631049, content=不说审稿，半个月才分配编辑，一个月以后编辑拒绝了。服了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceb95489920, createdName=ms6000000926635472, createdTime=Wed Feb 23 08:57:04 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193777, encodeId=07a41193e77fc, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:44:40 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083523, encodeId=3b58108352363, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：帕金森病 经验分享：2021/08/16 Manuscript Received、Editor Assigned、Manuscript Under Consideration 2021/08/24 Associate Editor assigned 2021/08/27 Manuscript Under Consideration 2021/09/01 Waiting to Send Decision to Author 2021/09/02 Editorial decision: Reject before peer review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK2qlPEOtMPgwAFQFLylicYibjJKOt9ns2DRjXGkG4jciaiaUAzChXicoiavRShXqte72eKZicwsIgEhGT3Q/132, createdBy=673d5265861, createdName=雪亦飘零久, createdTime=Thu Dec 23 12:04:05 CST 2021, time=2021-12-23, status=1, ipAttribution=)]

2021-12-23 雪亦飘零久

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：帕金森病
经验分享：2021/08/16 Manuscript Received、Editor Assigned、Manuscript Under Consideration
2021/08/24 Associate Editor assigned
2021/08/27 Manuscript Under Consideration
2021/09/01 Waiting to Send Decision to Author
2021/09/02 Editorial decision: Reject before peer review

138 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务